Option Care Health (NASDAQ:OPCH) Releases Earnings Results, Beats Estimates By $0.04 EPS

Option Care Health (NASDAQ:OPCH - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.22 by $0.04, Briefing.com reports. The business had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a return on equity of 18.78% and a net margin of 6.21%. The company's revenue was up 12.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.21 earnings per share. Option Care Health updated its FY 2024 guidance to EPS.

Option Care Health Stock Down 2.2 %

Shares of NASDAQ:OPCH traded down $0.66 on Wednesday, hitting $29.93. 2,826,835 shares of the company's stock were exchanged, compared to its average volume of 1,279,544. The firm's 50-day moving average is $32.13 and its 200 day moving average is $31.52. The company has a market capitalization of $5.20 billion, a PE ratio of 20.36, a P/E/G ratio of 1.73 and a beta of 1.22. Option Care Health has a 1-year low of $24.23 and a 1-year high of $35.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the stock in a transaction dated Monday, February 26th. The stock was acquired at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the transaction, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.64% of the company's stock.

Wall Street Analyst Weigh In

OPCH has been the topic of several research reports. Barrington Research restated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday. Jefferies Financial Group lifted their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "buy" rating in a research note on Monday, March 4th.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.